Nasal Nitric Oxide as an Objective Evaluation Tool for Treatment Response in Chronic Rhinitis
- Author:
Sangeun LEE
1
;
Su Mi SEONG
;
Hyeop OH
;
Jihun YOON
;
Bo Hae KIM
;
Joo Hyun PARK
;
Yun-Sung LIM
;
Chang Gun CHO
;
Seok-Won PARK
;
Jin Youp KIM
Author Information
- Publication Type:Original Article
- From:Journal of Rhinology 2025;32(1):40-47
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background and Objectives:Inconsistencies in nasal nitric oxide (nNO) values, due to anatomical variations and comorbidities, challenge the accurate assessment of upper airway inflammation severity. We hypothesized that changes in nNO levels following treatment for chronic rhinitis would be consistent and provide relative value. This study aimed to evaluate the correlation between changes in nNO levels and symptomatic improvements following treatment for chronic rhinitis.
Methods:This prospective observational study included 46 participants diagnosed with chronic rhinitis between December 2021 and November 2023. nNO measurements, evaluations of four nasal and two ocular symptoms, and quality of life questionnaires were conducted at baseline and after one month of treatment. Baseline laboratory tests included serum total immunoglobulin E levels, blood eosinophil percentages, and skin prick tests.
Results:The Total Nasal Symptom Score (TNSS), TNSS with ocular symptoms (TNSS eye), and Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores significantly decreased following treatment (all p<0.001). nNO levels also decreased significantly after treatment (p=0.036). Moreover, changes in nNO were significantly correlated with changes in TNSS, TNSS eye, and RQLQ scores (p=0.047, r=0.294; p=0.021, r=0.340; and p=0.004, r=0.419, respectively).
Conclusion:In patients with chronic rhinitis, changes in TNSS, TNSS eye, and RQLQ scores were correlated with changes in nNO levels after treatment. nNO may serve as a potential objective evaluation tool for chronic rhinitis, particularly in patients who have difficulty reporting symptoms.
